Shenzhen Pandao Biotechnology

Shenzhen, China Founded: 2013 • Age: 13 yrs
Healthcare information services are provided by the company in China.

About Shenzhen Pandao Biotechnology

Shenzhen Pandao Biotechnology is a company based in Shenzhen (China) founded in 2013. Healthcare information services are provided by the company in China. Shenzhen Pandao Biotechnology has raised $1.45 million across 1 funding round from investors including GP Capital. Shenzhen Pandao Biotechnology offers products and services including Gene Detection and Immune Function Detection. Its legal entity in India is ζ·±εœ³εΈ‚ζ½˜ι“η”Ÿη‰©η§‘ζŠ€ζœ‰ι™ε…¬εΈ (U99999MH1977PLC010754).

Company details

Shenzhen Pandao Biotechnology was founded in 2013 and is based in Shenzhen, China. Operations focus on the healthcare sector, where information services are delivered through digital platforms. Core activities include data management and analytics for medical applications, supporting clients in biotechnology and related fields. The domain pandobio.com serves as the primary online presence for these services, with emphasis on regional healthcare needs in Asia.

Key Metrics
  • Total Equity Funding
    $1.45M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.45M (USD), Series A

    Oct 2018

  • Investors

Products & Services of Shenzhen Pandao Biotechnology

Shenzhen Pandao Biotechnology offers a comprehensive portfolio of products and services, including Gene Detection and Immune Function Detection.

Gene Detection
Medical Testing

Gene detection services are provided for disease prevention and diagnostics in the healthcare sector.

Immune Function Detection
Diagnostic Services

Immune function detection is conducted using advanced tools to monitor health conditions.

Funding Insights of Shenzhen Pandao Biotechnology

Shenzhen Pandao Biotechnology has successfully raised a total of $1.45M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.45 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.45M
  • Total Rounds 1
  • Last Round Series A β€” $1.45M
  • First Round $1.45M

    (Oct 2018)

  • Investors Count 1

All 1 funding rounds of Shenzhen Pandao Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2018$1.45MSeries A––
Valuation history

1 investors in total: 1 institutional.

Investors in Shenzhen Pandao Biotechnology

Shenzhen Pandao Biotechnology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GP Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investments are provided by GP Capital to financial services companies.
gpcapital.com.cnShanghai, China
Premium access

Investor details for Shenzhen Pandao Biotechnology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Shenzhen Pandao Biotechnology

2 dated milestones of Shenzhen Pandao Biotechnology across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Shenzhen Pandao Biotechnology is founded.
  2. Funding First funding round of $1.5M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Shenzhen Pandao Biotechnology

Premium access

Complete news archive for Shenzhen Pandao Biotechnology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shenzhen Pandao Biotechnology

Shenzhen Pandao Biotechnology was founded in 2013 and raised its 1st funding round 5 years after it was founded.

Shenzhen Pandao Biotechnology is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Shenzhen Pandao Biotechnology is a funded company, having raised a total of $1.45M across 1 funding round to date. The company's 1st funding round was a Series A of $1.45M, raised on Oct 2018.

Shenzhen Pandao Biotechnology was founded in 2013 and is based in Shenzhen, China. Operations focus on the healthcare sector, where information services are delivered through digital platforms. Core activities include data management and analytics for medical applications, supporting clients in biotechnology and related fields. The domain pandobio.com serves as the primary online presence for these services, with emphasis on regional healthcare needs in Asia.

Shenzhen Pandao Biotechnology offers Gene Detection and Immune Function Detection.

Shenzhen Pandao Biotechnology has 1 investor. Key investors include GP Capital.

Shenzhen Pandao Biotechnology operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available